Marc D. Kozin
Director, UFP Technologies.
Companies
- Chimerix (United States)Board member Mar 21, 2024 to now1
- UFP TechnologiesBoard member Jun 9, 2006 to now2
- Notable Labs, Ltd.Board member Jan 3, 2023 to Jan 3, 20233
- Dicerna Pharmaceuticals (United States)Board member Jan 25, 2019 to Dec 29, 20214
- Isleworth Healthcare Acquisition Corp.Board member Feb 24, 2021 to Sep 10, 20215
- Tempest Therapeutics, Inc.Board member Jan 10, 2014 to Dec 11, 20186
- Decoy Therapeutics Inc.Board member Jan 28, 2015 to Jul 26, 20187
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- UFP Technologies UFPT21,112 shares8$6.3M at $297.19Aug 25, 2026
- Dicerna Pharmaceuticals (United States)0 shares9Dec 28, 2021
- Notable Labs, Ltd.39,000 shares10Jan 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 25, 2026Sold 3,350 shares at $305.07 of UFP Technologies8
- Aug 25, 2026Sold 3,650 shares at $303.97 of UFP Technologies8
- Jun 4, 2026Granted 802 shares of UFP Technologies11
- Jun 4, 2025Granted 625 shares of UFP Technologies12
- Sep 6, 2024Gift 1,500 shares of UFP Technologies13
- Jun 5, 2024Granted 230 shares of UFP Technologies14
- Jun 7, 2023Granted 298 shares of UFP Technologies15
- Mar 10, 2023Gift 1,000 shares of UFP Technologies16
- Jun 8, 2022Granted 647 shares of UFP Technologies17
- Dec 28, 2021Returned to company 5,000 shares at $38.25 of Dicerna Pharmaceuticals (United States)9
- Dec 28, 2021Returned to company 6,333 shares at $38.25 of Dicerna Pharmaceuticals (United States)9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARUFP Technologies, Board member
- 3SEC EDGARNotable Labs, Ltd., Board member
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 8, 2026
- 12SEC EDGARForm 4 filed Jun 6, 2025
- 13SEC EDGARForm 4 filed Oct 3, 2024
- 14SEC EDGARForm 4 filed Jun 7, 2024
- 15SEC EDGARForm 4 filed Jun 8, 2023
- 16SEC EDGARForm 4 filed Mar 10, 2023
- 17SEC EDGARForm 4 filed Jun 10, 2022